Approval · Notice of Compliance 1362 · 2000
LOSEC: Notice of Compliance 1362
Issued October 24, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1362
- Date
- October 24, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- H+, K+-atpase inhibitor
Products in this notice
Medicinal ingredients
- OMEPRAZOLE 10 MG per CAP
- OMEPRAZOLE 20 MG per CAP
- OMEPRAZOLE 40 MG per CAP